New medication increases HDL cholesterol and decreases LDL cholesterol levels
Wednesday, November 16, 2011 - 06:30
in Health & Medicine
Among patients with sub-optimal low-density lipoprotein cholesterol (LDL-C) or high-density lipoprotein cholesterol (HDL-C) levels, use of the drug evacetrapib alone or in combination with statin medications was associated with significant increases in HDL-C levels and decreases in LDL-C levels, according to a new study.